SCH708980

SCH708980 is a humanized monoclonal antibody inhibitor targeting IL-10. SCH708980 has anti-immunosuppressive activity. SCH708980 can be used for visceral leishmaniasis, sepsis-associated kidney injury (SAKI) and osteoporosis research[1][2][3].

Product Specifications

UNSPSC

12352100

Target

Interleukin Related

Related Pathways

Immunology/Inflammation

Applications

COVID-19-immunoregulation

Field of Research

Infection; Inflammation/Immunology

References & Citations

[1]Wang C, et al. Text Mining and Drug Discovery Analysis: A Comprehensive Approach to Investigate Diabetes-Induced Osteoporosis. Int J Med Sci. 2024 Jan 1;21 (3) :464-473.|[2]Sun S, et al. Identification of potential hub genes and drugs in septic kidney injury: a bioinformatic analysis with preliminary experimental validation. Front Med (Lausanne) . 2025 Mar 17;12:1502189. |[3]Vacchelli E, et al. Trial Watch: Immunostimulatory cytokines. Oncoimmunology. 2012 Jul 1;1 (4) :493-506.